Non-Invasive Aesthetic Treatment Market Size, Share, and Trends 2025 to 2034

The global non-invasive aesthetic treatment market was valued at USD 22.67 billion in 2025 and is projected to reach approximately USD 41.55 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.00% during the forecast period. This growth is driven by rising demand for minimally invasive cosmetic procedures, technological advancements, and increasing consumer focus on appearance with minimal downtime.

Last Updated : July 2025  |  Report Code : 1495  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Non-Invasive Aesthetic Treatment Market 

5.1. COVID-19 Landscape: Non-Invasive Aesthetic Treatment Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Non-Invasive Aesthetic Treatment Market, By Procedure

8.1. Non-Invasive Aesthetic Treatment Market, by Procedure Type

8.1.1. Injectable

8.1.1.1. Market Revenue and Forecast

8.1.2. Skin Rejuvenation

8.1.2.1. Market Revenue and Forecast

8.1.3. Others

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Non-Invasive Aesthetic Treatment Market, By End Use

9.1. Non-Invasive Aesthetic Treatment Market, by End Use

9.1.1. Hospitals & Surgery Centers

9.1.1.1. Market Revenue and Forecast

9.1.2. Medical Spa

9.1.2.1. Market Revenue and Forecast

9.1.3. Clinics

9.1.3.1. Market Revenue and Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Forecast

Chapter 10. Global Non-Invasive Aesthetic Treatment Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Procedure

10.1.2. Market Revenue and Forecast, by End Use

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Procedure

10.1.3.2. Market Revenue and Forecast, by End Use

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Procedure

10.1.4.2. Market Revenue and Forecast, by End Use

10.2. Europe

10.2.1. Market Revenue and Forecast, by Procedure

10.2.2. Market Revenue and Forecast, by End Use

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Procedure

10.2.3.2. Market Revenue and Forecast, by End Use

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Procedure

10.2.4.2. Market Revenue and Forecast, by End Use

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Procedure

10.2.5.2. Market Revenue and Forecast, by End Use

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Procedure

10.2.6.2. Market Revenue and Forecast, by End Use

10.3. APAC

10.3.1. Market Revenue and Forecast, by Procedure

10.3.2. Market Revenue and Forecast, by End Use

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Procedure

10.3.3.2. Market Revenue and Forecast, by End Use

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Procedure

10.3.4.2. Market Revenue and Forecast, by End Use

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Procedure

10.3.5.2. Market Revenue and Forecast, by End Use

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Procedure

10.3.6.2. Market Revenue and Forecast, by End Use

10.4. MEA

10.4.1. Market Revenue and Forecast, by Procedure

10.4.2. Market Revenue and Forecast, by End Use

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Procedure

10.4.3.2. Market Revenue and Forecast, by End Use

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Procedure

10.4.4.2. Market Revenue and Forecast, by End Use

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Procedure

10.4.5.2. Market Revenue and Forecast, by End Use

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Procedure

10.4.6.2. Market Revenue and Forecast, by End Use

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Procedure

10.5.2. Market Revenue and Forecast, by End Use

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Procedure

10.5.3.2. Market Revenue and Forecast, by End Use

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Procedure

10.5.4.2. Market Revenue and Forecast, by End Use

Chapter 11. Company Profiles

11.1. Galderma S.A.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Allergen

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. El. En. SpA

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Alma Lasers

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Johnson & Johnson

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Cynosure

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Solta Medical

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Syneron Candela

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Lumenis

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Merz Pharma

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global non-invasive aesthetic treatment market size was reached at USD 21.01 billion in 2024 and is projected to surpass USD 41.55 billion by 2034.

The global non-invasive aesthetic treatment market to garner growth at a CAGR of 7.00% from 2025 to 2034.

The global non-invasive aesthetic treatment market is primarily driven by the rising demand for the skin aging treatment among the aging population. Moreover various skin related issues among the young population also drives the growth of the market.

The leading players operating in the global non-invasive aesthetic treatment market are Galderma S.A., Allergen, El. En. SpA, Alma Lasers, Johnson & Johnson, Cynosure, Solta Medical, Syneron Candela, Lumenis, Merz Pharma.

North America dominated the global non-invasive aesthetic treatment market and accounted for a market share of more than 43% in 2024. US is the largest market in North America and across the globe.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client